TickerFactsScreenerDevelopers

PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) — Operating Income

Annual figures by fiscal year, from SEC filings.

2009: -$12.33M2010: -$20.69M2011: -$21.44M2012: -$14.34M2013: -$13.03M2014: -$12.63M2015: -$24.65M2016: -$24.51M2017: -$13.32M2018: -$8.05M2019: -$6.30M2020: -$4.96M2021: -$4.67M2022: -$3.43M2023: -$2.90M2024: -$4.53M2025: -$5.29M-$5.29M
2009Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$5.29M-16.8%
2024-$4.53M-56.2%
2023-$2.90M+15.4%
2022-$3.43M+26.6%
2021-$4.67M+5.9%
2020-$4.96M+21.2%
2019-$6.30M+21.8%
2018-$8.05M+39.5%
2017-$13.32M+45.7%
2016-$24.51M+0.6%
2015-$24.65M-95.2%
2014-$12.63M+3.0%
2013-$13.03M+9.1%
2012-$14.34M+33.1%
2011-$21.44M-3.6%
2010-$20.69M-67.9%
2009-$12.33M—